Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
Drug pricing is an increasingly complex area that combines business knowledge, the review of difficult and sometimes ambiguous regulations, and the understanding of industry practices.
United StatesFood, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.
Drug pricing is an increasingly complex area that combines
business knowledge, the review of difficult and sometimes ambiguous
regulations, and the understanding of industry practices. Our team
regularly provide advice, in-depth analyses and internal training
on calculating the various pricing metrics that are reported to
federal agencies or that set price ceilings (e.g., AMP, Best Price,
Section 340B, ASP, non-FAMP, and federal ceiling price), and on
related reporting and administrative requirements. We at Arnold
& Porter are here to help.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
Arnold & Porter Life Sciences: Pharmaceutical Pricing & Contracting (Video)
United StatesFood, Drugs, Healthcare, Life Sciences
Contributor
Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
